Andrew Cope

540 total citations
4 papers, 366 citations indexed

About

Andrew Cope is a scholar working on Rheumatology, Immunology and Infectious Diseases. According to data from OpenAlex, Andrew Cope has authored 4 papers receiving a total of 366 indexed citations (citations by other indexed papers that have themselves been cited), including 2 papers in Rheumatology, 2 papers in Immunology and 1 paper in Infectious Diseases. Recurrent topics in Andrew Cope's work include Rheumatoid Arthritis Research and Therapies (2 papers), SARS-CoV-2 and COVID-19 Research (1 paper) and Systemic Lupus Erythematosus Research (1 paper). Andrew Cope is often cited by papers focused on Rheumatoid Arthritis Research and Therapies (2 papers), SARS-CoV-2 and COVID-19 Research (1 paper) and Systemic Lupus Erythematosus Research (1 paper). Andrew Cope collaborates with scholars based in United Kingdom, Belgium and France. Andrew Cope's co-authors include Sophie Papa, Gincy George, Aida Santaolalla, Beth Russell, Charlotte Moss, Mieke Van Hemelrijck, Naeem Khan, Gary Middleton, Mark T. Drayson and Alex Richter and has published in prestigious journals such as Nature Communications, Annals of the Rheumatic Diseases and RMD Open.

In The Last Decade

Andrew Cope

4 papers receiving 356 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Andrew Cope United Kingdom	2	239	135	77	50	47	4	366
Yuzhang Wu China	4	279 1.2×	104 0.8×	49 0.6×	41 0.8×	35 0.7×	6	378
Jianzeng Zhang China	3	274 1.1×	131 1.0×	75 1.0×	34 0.7×	18 0.4×	7	436
Can Tu China	8	213 0.9×	110 0.8×	119 1.5×	69 1.4×	19 0.4×	17	369
Akansha Sinha Australia	3	254 1.1×	181 1.3×	30 0.4×	69 1.4×	30 0.6×	8	395
Roberto Bursi Italy	8	225 0.9×	84 0.6×	31 0.4×	48 1.0×	59 1.3×	14	431
Maxime Fauter France	6	353 1.5×	234 1.7×	42 0.5×	121 2.4×	76 1.6×	9	521
Hui Liao China	3	265 1.1×	155 1.1×	25 0.3×	55 1.1×	42 0.9×	3	366
Sophie Laplanche France	8	391 1.6×	218 1.6×	39 0.5×	150 3.0×	59 1.3×	16	592
Jiarui Feng China	8	244 1.0×	118 0.9×	124 1.6×	149 3.0×	15 0.3×	11	497

Countries citing papers authored by Andrew Cope

Since Specialization

Citations

This map shows the geographic impact of Andrew Cope's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Andrew Cope with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Andrew Cope more than expected).

Fields of papers citing papers by Andrew Cope

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Andrew Cope. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Andrew Cope. The network helps show where Andrew Cope may publish in the future.

Co-authorship network of co-authors of Andrew Cope

This figure shows the co-authorship network connecting the top 25 collaborators of Andrew Cope. A scholar is included among the top collaborators of Andrew Cope based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Andrew Cope. Andrew Cope is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

4 of 4 papers shown

1.

Maldonado, Manuel, M. Weinblatt, Andrew Cope, et al.. (2024). OP0007 SUBCUTANEOUS ABATACEPT VS ADALIMUMAB HEAD-TO-HEAD COMPARISON IN ADULTS WITH EARLY, DUAL SEROPOSITIVE RHEUMATOID ARTHRITIS, POSITIVE FOR THE SHARED EPITOPE HLA CLASS II RISK ALLELES, AND AN INADEQUATE RESPONSE TO METHOTREXATE: RESULTS FROM THE PHASE 3 AMPLIFIED TRIAL. Annals of the Rheumatic Diseases. 83. 79–80. 1 indexed citations

2.

Patel, Akshay J., Zena Willsmore, Naeem Khan, et al.. (2022). Regulatory B cell repertoire defects predispose lung cancer patients to immune-related toxicity following checkpoint blockade. Nature Communications. 13(1). 3148–3148. 41 indexed citations

3.

Reuter, Katja, Anna Moltó, Andrew Cope, et al.. (2022). Levelling the playing field of RMD research across Europe to address patients’ needs: the emerging EULAR Research Centre. RMD Open. 8(2). e002456–e002456. 1 indexed citations

4.

Russell, Beth, Charlotte Moss, Gincy George, et al.. (2020). Associations between immune-suppressive and stimulating drugs and novel COVID-19—a systematic review of current evidence. ecancermedicalscience. 14. 1022–1022. 323 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact